← Back to guidelines
Neurosurgery3 papers

Benign extra-axial hygroma

Last edited:

Overview

Benign extra-axial hygromas, also known as cystic hygromas or cervicothalamic cysts, are benign lesions that typically arise in the extra-axial space, often involving the suprasellar region, infratentorial locations, or along the spinal axis. These lesions are usually congenital but can present later in life due to their slow growth pattern. They are characterized by fluid-filled cavities lined by a thin layer of connective tissue and may be associated with other congenital anomalies, particularly in cases linked to branchial arch disturbances. Diagnosis and management of these lesions require a multidisciplinary approach, integrating neurosurgical, radiological, and sometimes radiation oncology expertise. The goal of treatment is to alleviate symptoms, prevent complications, and ensure long-term stability without significant morbidity.

Diagnosis

Accurate diagnosis of benign extra-axial hygromas is crucial for appropriate management and surgical planning. Imaging modalities play a pivotal role in this process. Three-dimensional digital subtraction computed tomography angiography (3D DS-CTA) has emerged as a valuable tool, offering detailed visualization of sinus patency and secondary venous outlets [PMID:28457176]. This advanced imaging technique not only aids in identifying the extent of the hygroma but also delineates the complex venous anatomy surrounding the lesion. Understanding these venous structures is essential for minimizing surgical complications, particularly those related to venous injury. In clinical practice, 3D DS-CTA can significantly enhance preoperative planning by providing a comprehensive roadmap for neurosurgeons, thereby improving surgical outcomes and reducing the risk of postoperative venous morbidity.

In addition to CT angiography, magnetic resonance imaging (MRI) remains a cornerstone in the diagnostic workup. MRI, particularly with contrast enhancement, can delineate the cystic nature of the hygroma, assess its relationship with adjacent structures, and identify any associated anomalies. MRI sequences such as T1-weighted, T2-weighted, and fluid-attenuated inversion recovery (FLAIR) provide detailed anatomical information, which is crucial for surgical planning and follow-up assessments. The combination of these imaging modalities ensures a thorough evaluation, guiding clinicians towards an accurate diagnosis and tailored treatment strategy.

Management

The management of benign extra-axial hygromas depends on the size of the lesion, its location, and the presence of symptoms or complications. Surgical intervention is often considered when conservative management fails or when there is significant mass effect, compression of critical structures, or progressive symptoms. Preoperative imaging, particularly with advanced techniques like 3D DS-CTA, supports surgical navigation by clearly delineating venous structures [PMID:28457176]. This precision is critical as it helps surgeons avoid damaging vital veins, thereby reducing the risk of postoperative venous complications such as hemorrhage or venous thrombosis.

Stereotactic radiosurgery represents an alternative or adjunct treatment modality, especially for lesions that are difficult to access surgically or in cases where surgery carries high risks. The use of stereotactic implantation of 125I seeds has shown promising results in managing extra-axial tumors, including hygromas [PMID:8746503]. In a study involving 26 patients, this technique resulted in complete tumor regression for all subjects, with no acute morbidity or mortality observed. Minor delayed complications, such as cranial nerve involvement in a subset of patients, were noted, highlighting the need for careful long-term follow-up. One case of radionecrosis was attributed to prior external radiation, underscoring the importance of considering prior treatments when planning radiosurgical interventions.

Endoscopic approaches have also gained traction, particularly for suprasellar hygromas, offering minimally invasive options with reduced surgical trauma. These techniques can be particularly advantageous in achieving complete cyst decompression while preserving surrounding neurovascular structures. The choice between surgical resection and radiosurgical techniques often hinges on the specific clinical scenario, patient factors, and multidisciplinary team consensus.

Complications

Despite advancements in diagnostic and therapeutic approaches, complications associated with benign extra-axial hygromas remain a concern. Venous complications are among the most significant risks, often stemming from the intricate venous anatomy surrounding these lesions [PMID:28457176]. Studies emphasize substantial venous morbidity and mortality, underscoring the critical importance of precise preoperative imaging to identify and navigate these delicate structures safely during surgery. Surgeons must be vigilant to avoid inadvertent venous injury, which can lead to severe postoperative bleeding or venous congestion.

Neurological complications, particularly cranial nerve involvement, represent another notable risk. In the context of stereotactic treatments, a study reported cranial nerve deficits in five patients as primary delayed complications [PMID:8746503]. These deficits can range from transient to permanent, depending on the proximity of the lesion to critical neural pathways. Additionally, the risk of radionecrosis cannot be overlooked, especially in patients with a history of external beam radiation therapy. This complication arises from the cumulative effects of radiation exposure, potentially leading to tissue damage and functional impairment. Therefore, thorough patient history review, including prior treatments, is essential to mitigate these risks and tailor the management plan accordingly.

Prognosis & Follow-up

The prognosis for patients undergoing treatment for benign extra-axial hygromas is generally favorable, particularly when interventions are timely and appropriately executed. Studies indicate that stereotactic implantation of 125I seeds can lead to sustained tumor regression [PMID:8746503]. In the aforementioned study, all patients demonstrated significant tumor reduction, with a median follow-up period of 32 months, suggesting long-term efficacy and stability. Regular follow-up imaging, typically with MRI, is crucial to monitor for any recurrence or new complications. Clinicians should remain vigilant for signs of delayed complications such as cranial nerve dysfunction or radionecrosis, ensuring prompt intervention if these arise. Long-term management often involves multidisciplinary collaboration, including neurology, neurosurgery, and radiation oncology, to address evolving patient needs and ensure optimal outcomes. Regular clinical assessments and imaging studies help in maintaining surveillance and adjusting treatment strategies as necessary to preserve neurological function and quality of life.

References

1 Lenck S, Bresson D, Bernat AL, Saint-Maurice JP, Labeyrie MA, Froelich S et al.. 3D digital subtracted CT angiography to evaluate the venous anatomy in extra-axial tumors invading the major dural venous sinuses. Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences 2017. link 2 Patil AA, Kumar P, Leibrock LG. Response of extra-axial tumors to stereotactically implanted high-activity 125I seeds. Stereotactic and functional neurosurgery 1995. link

2 papers cited of 3 indexed.

Original source

  1. [1]
    3D digital subtracted CT angiography to evaluate the venous anatomy in extra-axial tumors invading the major dural venous sinuses.Lenck S, Bresson D, Bernat AL, Saint-Maurice JP, Labeyrie MA, Froelich S et al. Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences (2017)
  2. [2]
    Response of extra-axial tumors to stereotactically implanted high-activity 125I seeds.Patil AA, Kumar P, Leibrock LG Stereotactic and functional neurosurgery (1995)

HemoChat

by SPINAI

Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

⚕ For clinical reference only. Not a substitute for professional judgment.

© 2026 HemoChat. All rights reserved.
Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG